Advertisement
Advertisement
U.S. markets open in 8 hours 17 minutes
Advertisement
Advertisement
Advertisement
Advertisement

Enzon Pharmaceuticals, Inc. (ENZN)

Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
0.3780-0.0120 (-3.08%)
At close: 02:14PM EST
Advertisement
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Previous Close0.3900
Open0.3800
Bid0.3800 x 3000
Ask1.4100 x 200
Day's Range0.3602 - 0.3800
52 Week Range0.1600 - 0.8500
Volume26,800
Avg. Volume53,029
Market Cap28.053M
Beta (5Y Monthly)0.10
PE Ratio (TTM)N/A
EPS (TTM)N/A
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateSep 30, 2019
1y Target EstN/A
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
N/A

Subscribe to Yahoo Finance Plus to view Fair Value for ENZN

Learn more
View details
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
  • ENZON PHARMACEUTICALS INC
    Analyst Report: Pfizer Inc.Pfizer is one of the world's largest pharmaceutical firms, with annual sales close to $50 billion (excluding COVID-19 vaccine sales). While it historically sold many types of healthcare products and chemicals, now, prescription drugs and vaccines account for the majority of sales. Top sellers include pneumococcal vaccine Prevnar 13, cancer drug Ibrance, cardiovascular treatment Eliquis, and immunology drug Xeljanz. Pfizer sells these products globally, with international sales representing close to 50% of its total sales. Within international sales, emerging markets are a major contributor.
    Rating
    Fair Value
    Economic Moat
    13 hours agoMorningstar
View more
  • We're sorry we weren't able to find anything about this topic.

Advertisement
Advertisement